Literature DB >> 32314057

Can we use MRI to detect clinically silent recurrent soft-tissue sarcoma?

Anna Hirschmann1,2, Veroniek M van Praag3, Rick L Haas4,5, Michiel A J van de Sande3, Johan L Bloem6.   

Abstract

PURPOSE: The impact of MRI on early detection of local recurrence (LR) in high-grade soft-tissue sarcomas (STS) is unsubstantiated. To identify the contribution of MRI criteria including dynamic contrast-enhanced (DCE) MRI and knowledge of surgical margins that can be used in detecting recurrence prior to obvious proven presence of LR in soft-tissue sarcomas. The secondary aim was to determine causes for misdiagnosing LR.
METHODS: MRI of 23 patients (12 men; mean age, 59.7 years ± 16.5 years) with LR of STS and that of 22 age- and histology-matched controls with STS but without LR were retrospectively analyzed by two musculoskeletal radiologists. Preoperative MRI characteristics (conventional and DCE) were compared to those of MRIs made after treatment, but before LR was proven. Likelihood of recurrence was rated on a 5-point Likert scale for morphological and dynamic assessment separately, before and after adding knowledge of surgical margins. Descriptive statistics and receiver operating characteristic analysis were performed.
RESULTS: Differentiation of LR from post-therapeutic changes was the highest combining result of conventional MRI, DCE-MRI, and knowledge of surgical margins (area under the curve (AUC) 0.779), followed by DCE-MRI (AUC 0.706) and conventional MRI (AUC 0.648). Suboptimal MRI technique and overcalling post-therapeutic changes in microscopic positive margins were the main reasons for false negative and false positive results, respectively.
CONCLUSION: MRI including DCE improves the detection of recurrent, clinically silent soft-tissue sarcoma when combined with knowledge of achieved surgical margins. LR may be missed on inadequate MRI protocols. KEY POINTS: • Dynamic contrast-enhanced MRI is useful in the differentiation of recurrent soft-tissue sarcoma and post-therapeutic fibrosis. • Knowledge of surgical margins substantially increases the value of MRI in detecting recurrent soft-tissue sarcoma. • MR with all three image orientations, covering the entire part of the extremity in at least one sequence and comparison to initial tumor characteristics and location, is beneficial.

Entities:  

Keywords:  Magnetic resonance imaging; Recurrence; Sarcoma; Surgical margins; Surveillance

Year:  2020        PMID: 32314057     DOI: 10.1007/s00330-020-06810-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  4 in total

1.  Whole-tumor 3D volumetric MRI-based radiomics approach for distinguishing between benign and malignant soft tissue tumors.

Authors:  Brandon K K Fields; Natalie L Demirjian; Darryl H Hwang; Bino A Varghese; Steven Y Cen; Xiaomeng Lei; Bhushan Desai; Vinay Duddalwar; George R Matcuk
Journal:  Eur Radiol       Date:  2021-04-23       Impact factor: 5.315

2.  Diagnostic performance of MRI in detecting locally recurrent soft tissue sarcoma: systematic review and meta-analysis.

Authors:  Robert M Kwee; Thomas C Kwee
Journal:  Eur Radiol       Date:  2022-01-12       Impact factor: 5.315

3.  Detection of Soft Tissue Sarcoma Recurrence: Feasibility of Ultrafast 3D Gradient-Echo Sequence in Addition to Conventional Contrast-Enhanced MRI to Provide Early-Phase Postcontrast Information.

Authors:  Hye Min Son; Hye Jin Yoo; Sung Hwan Hong; Ja Young Choi; Hee Dong Chae
Journal:  J Belg Soc Radiol       Date:  2022-05-27       Impact factor: 1.912

Review 4.  Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders.

Authors:  Alexandros Marios Sofias; Federica De Lorenzi; Quim Peña; Armin Azadkhah Shalmani; Mihael Vucur; Jiong-Wei Wang; Fabian Kiessling; Yang Shi; Lorena Consolino; Gert Storm; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2021-06-15       Impact factor: 15.470

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.